Sat, Aug 23, 2014, 4:27 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • efficient_frontier2002 efficient_frontier2002 Aug 24, 2010 4:03 PM Flag

    News -- STA-9090 in Combination with Docetaxel

    http://www.foiservices.com/brochure/offpatent2010.cfm

    From the above link: "Used to treat breast, lung, prostate, stomach and head/neck cancers, docetaxel generates roughly $2 billion/year for Sanofi-Aventis."

    ($2 billion is 17 times SNTA's market cap, BTW.)

    From SNTA's 8/24/10 press release:
    “The combination of STA-9090 and docetaxel could possibly expand the therapeutic potential of both agents.”

    I'm not close to being a biotech expert, but it sounds like SNTA's HSP-9090 may not only save Sanofi-Aventis's docetaxel from going off-patent in a few years, but more importantly, create a much improved combination drug.

    Of course this is just one of many opportunities for STA-9090 -- doktorr_demento's recent 5-star post discusses many more.

    Comments are welcome.

 
SNTA
4.00+0.03(+0.76%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.